Cargando…
A V(H)1-69 antibody lineage from an infected Chinese donor potently neutralizes HIV-1 by targeting the V3 glycan supersite
An oligomannose patch around the V3 base of HIV-1 envelope glycoprotein (Env) is recognized by multiple classes of broadly neutralizing antibodies (bNAbs). Here, we investigated the bNAb response to the V3 glycan supersite in an HIV-1–infected Chinese donor by Env-specific single B cell sorting, str...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7494343/ https://www.ncbi.nlm.nih.gov/pubmed/32938661 http://dx.doi.org/10.1126/sciadv.abb1328 |
_version_ | 1783582730398728192 |
---|---|
author | Kumar, Sonu Ju, Bin Shapero, Benjamin Lin, Xiaohe Ren, Li Zhang, Lei Li, Dan Zhou, Zehua Feng, Yi Sou, Cindy Mann, Colin J. Hao, Yanling Sarkar, Anita Hou, Jiali Nunnally, Christian Hong, Kunxue Wang, Shuo Ge, Xiangyang Su, Bin Landais, Elise Sok, Devin Zwick, Michael B. He, Linling Zhu, Jiang Wilson, Ian A. Shao, Yiming |
author_facet | Kumar, Sonu Ju, Bin Shapero, Benjamin Lin, Xiaohe Ren, Li Zhang, Lei Li, Dan Zhou, Zehua Feng, Yi Sou, Cindy Mann, Colin J. Hao, Yanling Sarkar, Anita Hou, Jiali Nunnally, Christian Hong, Kunxue Wang, Shuo Ge, Xiangyang Su, Bin Landais, Elise Sok, Devin Zwick, Michael B. He, Linling Zhu, Jiang Wilson, Ian A. Shao, Yiming |
author_sort | Kumar, Sonu |
collection | PubMed |
description | An oligomannose patch around the V3 base of HIV-1 envelope glycoprotein (Env) is recognized by multiple classes of broadly neutralizing antibodies (bNAbs). Here, we investigated the bNAb response to the V3 glycan supersite in an HIV-1–infected Chinese donor by Env-specific single B cell sorting, structural and functional studies, and longitudinal analysis of antibody and virus repertoires. Monoclonal antibodies 438-B11 and 438-D5 were isolated that potently neutralize HIV-1 with moderate breadth, are encoded by the V(H)1-69 germline gene, and have a disulfide-linked long HCDR3 loop. Crystal structures of Env-bound and unbound antibodies revealed heavy chain–mediated recognition of the glycan supersite with a unique angle of approach and a critical role of the intra-HCDR3 disulfide. The mechanism of viral escape was examined via single-genome amplification/sequencing and glycan mutations around the N332 supersite. Our findings further emphasize the V3 glycan supersite as a prominent target for Env-based vaccine design. |
format | Online Article Text |
id | pubmed-7494343 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | American Association for the Advancement of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-74943432020-09-23 A V(H)1-69 antibody lineage from an infected Chinese donor potently neutralizes HIV-1 by targeting the V3 glycan supersite Kumar, Sonu Ju, Bin Shapero, Benjamin Lin, Xiaohe Ren, Li Zhang, Lei Li, Dan Zhou, Zehua Feng, Yi Sou, Cindy Mann, Colin J. Hao, Yanling Sarkar, Anita Hou, Jiali Nunnally, Christian Hong, Kunxue Wang, Shuo Ge, Xiangyang Su, Bin Landais, Elise Sok, Devin Zwick, Michael B. He, Linling Zhu, Jiang Wilson, Ian A. Shao, Yiming Sci Adv Research Articles An oligomannose patch around the V3 base of HIV-1 envelope glycoprotein (Env) is recognized by multiple classes of broadly neutralizing antibodies (bNAbs). Here, we investigated the bNAb response to the V3 glycan supersite in an HIV-1–infected Chinese donor by Env-specific single B cell sorting, structural and functional studies, and longitudinal analysis of antibody and virus repertoires. Monoclonal antibodies 438-B11 and 438-D5 were isolated that potently neutralize HIV-1 with moderate breadth, are encoded by the V(H)1-69 germline gene, and have a disulfide-linked long HCDR3 loop. Crystal structures of Env-bound and unbound antibodies revealed heavy chain–mediated recognition of the glycan supersite with a unique angle of approach and a critical role of the intra-HCDR3 disulfide. The mechanism of viral escape was examined via single-genome amplification/sequencing and glycan mutations around the N332 supersite. Our findings further emphasize the V3 glycan supersite as a prominent target for Env-based vaccine design. American Association for the Advancement of Science 2020-09-16 /pmc/articles/PMC7494343/ /pubmed/32938661 http://dx.doi.org/10.1126/sciadv.abb1328 Text en Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC). https://creativecommons.org/licenses/by-nc/4.0/ https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license (https://creativecommons.org/licenses/by-nc/4.0/) , which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited. |
spellingShingle | Research Articles Kumar, Sonu Ju, Bin Shapero, Benjamin Lin, Xiaohe Ren, Li Zhang, Lei Li, Dan Zhou, Zehua Feng, Yi Sou, Cindy Mann, Colin J. Hao, Yanling Sarkar, Anita Hou, Jiali Nunnally, Christian Hong, Kunxue Wang, Shuo Ge, Xiangyang Su, Bin Landais, Elise Sok, Devin Zwick, Michael B. He, Linling Zhu, Jiang Wilson, Ian A. Shao, Yiming A V(H)1-69 antibody lineage from an infected Chinese donor potently neutralizes HIV-1 by targeting the V3 glycan supersite |
title | A V(H)1-69 antibody lineage from an infected Chinese donor potently neutralizes HIV-1 by targeting the V3 glycan supersite |
title_full | A V(H)1-69 antibody lineage from an infected Chinese donor potently neutralizes HIV-1 by targeting the V3 glycan supersite |
title_fullStr | A V(H)1-69 antibody lineage from an infected Chinese donor potently neutralizes HIV-1 by targeting the V3 glycan supersite |
title_full_unstemmed | A V(H)1-69 antibody lineage from an infected Chinese donor potently neutralizes HIV-1 by targeting the V3 glycan supersite |
title_short | A V(H)1-69 antibody lineage from an infected Chinese donor potently neutralizes HIV-1 by targeting the V3 glycan supersite |
title_sort | v(h)1-69 antibody lineage from an infected chinese donor potently neutralizes hiv-1 by targeting the v3 glycan supersite |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7494343/ https://www.ncbi.nlm.nih.gov/pubmed/32938661 http://dx.doi.org/10.1126/sciadv.abb1328 |
work_keys_str_mv | AT kumarsonu avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT jubin avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT shaperobenjamin avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT linxiaohe avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT renli avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT zhanglei avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT lidan avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT zhouzehua avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT fengyi avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT soucindy avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT manncolinj avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT haoyanling avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT sarkaranita avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT houjiali avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT nunnallychristian avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT hongkunxue avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT wangshuo avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT gexiangyang avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT subin avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT landaiselise avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT sokdevin avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT zwickmichaelb avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT helinling avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT zhujiang avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT wilsoniana avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT shaoyiming avh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT kumarsonu vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT jubin vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT shaperobenjamin vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT linxiaohe vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT renli vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT zhanglei vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT lidan vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT zhouzehua vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT fengyi vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT soucindy vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT manncolinj vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT haoyanling vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT sarkaranita vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT houjiali vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT nunnallychristian vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT hongkunxue vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT wangshuo vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT gexiangyang vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT subin vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT landaiselise vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT sokdevin vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT zwickmichaelb vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT helinling vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT zhujiang vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT wilsoniana vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite AT shaoyiming vh169antibodylineagefromaninfectedchinesedonorpotentlyneutralizeshiv1bytargetingthev3glycansupersite |